MX$ 20.31
Key Takeaways
Risk factor
Strong & resilient to price shocks
Profitability factor
Undervalued vs peers
About
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA,
Target Price
The average target price of LABB.MX is 31 and suggests 55% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
